A long-term partnership has been established between the Institute of Drug Quality Control in Ho Chi Minh City and Saigon Pharmaceutical One Member Limited Liability Company (Sapharco) to enhance quality standards and pharmaceutical manufacturing capabilities in the southern region.
Key cooperation pillars Based on the memorandum of understanding, the two entities will focus on four core areas:
-
R&D and Technology: Implementing scientific research, experimental production projects, and transferring advanced pharmaceutical manufacturing processes.
-
Quality Control: Collaborating on sample testing, monitoring pharmaceutical standards, and calibrating specialized analytical equipment systems.
-
Human Resource Development: Cultivating a team of highly skilled experts to meet the rigorous demands of the healthcare market.
-
Infrastructure Development: Aiming to establish a clinical trial center and expand the healthcare delivery system.
Vision and market context With the southern pharmaceutical market accounting for 70% of the national scale, this collaboration between a professional verification body and a manufacturing-distribution unit is expected to address the demand for high-tech medication. According to the strategic vision for the 2040-2045 period, this partnership model aims to create economic breakthroughs for the local budget while ensuring consumer safety amid market quality challenges.